This summary was created by AI, based on 3 opinions in the last 12 months.
Rambus Inc. (RMBS) has been reviewed positively in recent analyses, particularly due to its role in developing computer chips that power AI technologies. The company currently trades at appealing earnings multiples, notably a price-to-earnings ratio of approximately 20x, alongside a strong return on equity of 41%. Recent earnings news is anticipated on July 29, which has analysts advising to set a stop-loss at $53 while still aiming for significant upside potential. There are also positions advocating for trailing stop adjustments and highlighting the company’s proactive strategies, such as share buybacks and debt reduction. With a strong market focus on DDR5 semiconductor chips and a potential for growth ahead, investors are encouraged to consider the stock's positive trajectory despite recently triggered stop-losses.
High speed chip to chop interface is making a comeback, and RMBS makes money though it took a while.
Rambus Inc. is a American stock, trading under the symbol RMBS-Q on the NASDAQ (RMBS). It is usually referred to as NASDAQ:RMBS or RMBS-Q
In the last year, 2 stock analysts published opinions about RMBS-Q. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Rambus Inc..
Rambus Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Rambus Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
2 stock analysts on Stockchase covered Rambus Inc. In the last year. It is a trending stock that is worth watching.
On 2025-02-28, Rambus Inc. (RMBS-Q) stock closed at a price of $55.89.
Our PAST TOP PICK with RMBS has triggered its stop at $53. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 12%, when combined with our previous recommendations.